Saturday 17 October 2026
Export CON’s income statement to Excel — free account
Concentra Group Holdings Parent, Inc.
CON Healthcare Medical Care Facilities
Concentra Group Holdings Parent, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 13.9% from fiscal 2024. In the quarter to June 2026, revenue grew 10.0%, EPS grew 45.7%, free cash flow grew 91.6% and total debt fell 5.54%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
38.54
0.61
−1.56%
Follow CON
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | |
|---|---|---|---|---|---|
P/E ratio |
15.14 | 13.10 | 11.17 | 11.17 | 11.17 |
Piotroski F-Score |
6 | 4 | — | — | — |
Altman Z-Score |
1.85 | 1.83 | — | — | — |
P/S ratio |
1.17 | 1.19 | 1.24 | 1.24 | 1.24 |
Altman Z″-Score (non-manufacturers) |
1.23 | 1.30 | 2.88 | 2.27 | — |
P/FCF ratio |
12.76 | 10.74 | 13.13 | 13.13 | 13.13 |
Beneish M-Score |
(2.49) | (3.06) | (2.46) | — | — |
P/Operating CF |
21.27 | 24.10 | 33.22 | 33.22 | 33.22 |
Dividend Safety Score |
62 | — | — | — | — |
P/B ratio |
6.30 | 8.05 | 1.87 | 1.87 | 1.87 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.86 | 1.87 | 1.44 | 1.44 | 1.44 |
EV/EBITDA |
9.71 | 9.51 | 7.21 | 7.21 | 7.21 |
EV/Operating CF |
14.39 | 12.94 | 10.88 | 10.88 | 10.88 |
EV/FCF |
20.32 | 16.90 | 15.24 | 15.24 | 15.24 |
Quick Ratio |
1.00 | 1.31 | 0.90 | 0.87 | — |
Current Ratio |
1.14 | 1.42 | 1.07 | 1.02 | — |
Net Debt/EBITDA |
3.61 | 3.47 | 1.23 | 1.80 | 0.00 |
Debt/Assets |
55.08% | 58.66% | 20.34% | 27.67% | 0.00% |
Debt/Equity |
3.93 | 5.27 | 0.41 | 0.65 | 0.00 |
Asset Turnover |
0.80 | 0.78 | 0.79 | 1.50 | 0.00 |
Operating CF/Net income |
1.68 | 1.65 | 1.30 | 1.65 | 1.39 |
Capex/Depreciation |
(1.02) | (0.93) | (0.89) | (0.62) | (0.51) |
Interest Coverage |
3.06 | 4.37 | 6.47 | 8.17 | 9.58 |
| 48.82% | 23.10% | 16.82% | 0.00% | 0.00% | |
| 6.19% | 6.86% | 7.77% | 14.52% | 0.00% | |
ROIC |
11.01% | 12.08% | 11.21% | 10.24% | 0.00% |
Return on Tangible Assets |
61.37% | 50.78% | 90.81% | 101.74% | 0.00% |
Average Days of Receivables |
43.51 | 41.82 | 42.93 | 43.66 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
9.40% | 8.23% | 8.27% | 8.70% | 9.11% |
Intangible Assets out of Total Assets |
0.60 | 0.57 | 0.62 | 0.58 | 0.00 |
Share Based Compensation of Revenue |
0.48% | 0.12% | 0.04% | 0.12% | 0.12% |
Graham Net Nets |
(0.82) | (0.80) | (0.34) | (0.34) | (0.34) |
Graham Number |
9.56 | 9.14 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
6.61% | 7.63% | 8.95% | 8.95% | 8.95% |
Free Cash Flow Yield |
7.84% | 9.31% | 7.62% | 7.62% | 7.62% |
Revenue per Share |
16.86 | 16.64 | 17.64 | 16.55 | 16.47 |
Operating CF per Share |
2.18 | 2.41 | 2.25 | 2.63 | 2.76 |
Capex per Share |
(0.64) | (0.56) | (0.62) | (0.44) | (0.40) |
Free Cash Flow per Share |
1.54 | 1.84 | 1.63 | 2.19 | 2.37 |
Cash per Share |
0.62 | 1.60 | 0.30 | 0.36 | 0.00 |
Shareholders Equity per Share |
3.13 | 2.46 | 11.14 | 9.40 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.13 | 2.46 | 11.14 | 9.40 | 0.00 |
Free Cash Flow |
197.84 | 210.38 | 169.39 | 228.39 | 248.94 |
Working Capital |
45.85 | 130.02 | 19.78 | 5.00 | — |
Capital Expenditures |
(81.56) | (64.30) | (64.92) | (45.94) | (41.70) |
Net Current Asset Value |
(2,074.26) | (1,803.25) | (878.18) | (1,033.26) | 0.00 |
EV/EBIT |
12.03 | 11.66 | 8.43 | 8.43 | 8.43 |
Capex to Sales |
0.04 | 0.03 | 0.04 | 0.03 | 0.02 |
Price to Operating Income |
7.56 | 7.41 | 7.26 | 7.26 | 7.26 |
| Other line items | |||||
Depreciation/Fixed assets |
0.35 | 0.35 | 0.41 | 0.46 | 0.00 |
Cash ROIC |
9.63% | 10.83% | 10.16% | 13.82% | 0.00% |
Accounts Receivable Turnover |
9.10 | 8.76 | 8.70 | 0.00 | 0.00 |
Accounts Payable Turnover |
76.08 | 68.33 | 55.14 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
4.95 | 5.25 | 5.62 | 8.13 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
237.81 | 216.96 | 211.23 | — | — |
Average Payables |
20.38 | 20.08 | 24.04 | — | — |
Average Assets |
2,689.78 | 2,427.36 | 2,315.40 | 1,148.62 | — |
Average Common Equity |
340.87 | 720.84 | 1,070.15 | — | — |
Columns are period end dates